iFyber to exhibit at SAWC Fall in Las Vegas
Using the AATCC 100 Method to Evaluate Antimicrobial Efficacy for Wound Care Products
Why does the AATCC 100 test method hold the FDA’s attention when evaluating the efficacy of wound care products? In the realm of wound care, the prevention of infections is paramount for supporting patient healing. According to Abdullah Ibn Mafiz, PhD, and Principal Investigator at iFyber, antimicrobial wound care products act as defenders of the…
Read More LAMP Assays: Revolutionizing Point-of-Care and At-Home Diagnostics
In the ever-evolving world of medical diagnostics, the need for rapid and accessible testing has never been more crucial. The demand for tests that can be conducted swiftly at the point of care or even in the comfort of our homes has gained significant importance. Loop-Mediated Isothermal Amplification (LAMP) assays are emerging as a transformative force…
Read More From Clinical Lab Assay to At-Home and Point-of-Care Testing
The world of healthcare is constantly evolving, and recent years have witnessed a significant shift from traditional clinical lab assays to at-home and point-of-care testing. A need for more patient-centric, accessible, and efficient healthcare drives this transformation. Mariely Medina-Rivera, a Research Scientist at iFyber, explains the steps involved in advancing Point of Care (POC) and…
Read More Choosing between Immunoassays and Molecular Assays
Immunoassays and molecular assays are two distinct diagnostic tests used in healthcare and research, each with unique characteristics and applications. Immunoassays are widely used in clinical diagnostics, disease monitoring, and drug testing. They are employed to measure specific proteins or antigens. On the other hand, molecular assays are vital for genetic testing, pathogen detection, and…
Read More